Skip to main content
SpringerLink
Log in

Tardive and Neuroleptic-Induced Emergencies

  • Chapter
  • First Online:
Movement Disorder Emergencies

Part of the book series: Current Clinical Neurology ((CCNEU))

  • 1845 Accesses

Abstract

Tardive and neuroleptic-induced movement disorders can be among the most dramatic conditions affecting patients. One has only to witness a patient with severe acute jaw dystonia from haloperidol, or watch a patient develop neuroleptic-induced oculogyric crisis to appreciate how sudden and devastating these disorders can be. Fortunately, prompt recognition and treatment are usually effective and, occasionally, lifesaving. This chapter reviews tardive and neuroleptic-induced movement disorder emergencies, and their diagnosis and management.

This chapter contains video segments that can be found on the accompanying DVD.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 159.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fitzgerald PM, Jankovic J. Tardive oculogyric crises. Neurology. 1989;39:1434–7.

    Article  PubMed  CAS  Google Scholar 

  2. Albers VA, Catalano G, Poole MA. Tardive dyskinesia as a result of long-term prochlorperazine use. South Med J. 1996;89:989–91.

    Article  Google Scholar 

  3. Ganzini L, Casey DE, Hoffman WF, McCall AL. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders. Arch Intern Med. 1993;153:1469–75.

    Article  PubMed  CAS  Google Scholar 

  4. Micheli FE, Pardal MM, Giannaula R, et al. Movement disorders and depression due to flunarizine and cinnarizine. Mov Disord. 1989;4:139–46.

    Article  PubMed  CAS  Google Scholar 

  5. Mejia NI, Jankovic J. Metoclopramide-induced tardive dyskinesia in an infant. Mov Disord. 2005;20:86–9.

    Article  PubMed  Google Scholar 

  6. Manji H, Howard RS, Miller DH, et al. Status dystonicus: the syndrome and its management. Brain. 1998;121:243–52.

    Article  PubMed  Google Scholar 

  7. Koek RJ, Pi EH. Acute laryngeal dystonic reactions to neuroleptics. Psychosomatics. 1989;30:359–64.

    Article  PubMed  CAS  Google Scholar 

  8. Rowley H, Lynch T, Keogh I, Russell J. Tardive dystonia of the larynx in a quadriplegic patient: an unusual cause of stridor. J Laryngol Otol. 2001;115:918–9.

    Article  PubMed  CAS  Google Scholar 

  9. Casey DE, Rabins P. Tardive dyskinesias as a life-threatening illness. Am J Psychiatry. 1978;135:486–8.

    PubMed  CAS  Google Scholar 

  10. Yassa R, Lal S. Respiratory irregularity and tardive dyskinesia. Acta Psychiatr Scand. 1986;74:506–10.

    Article  Google Scholar 

  11. Greene PE, Kang UJ, Fahn S. Spread of symptoms in idiopathic torsion dystonia. Mov Disord. 1995;10:143–52.

    Article  PubMed  CAS  Google Scholar 

  12. Sachdev PS, Singh S. Dyskinesia presenting as a respiratory emergency. Med J Aust. 1994;161:726–7.

    PubMed  CAS  Google Scholar 

  13. Nishikawa T, Kandea W, Uegaki A, Koga I, Uchida Y, Tanaka M. Respiratory dyskinesia: a variety of clinical forms differentially diagnosed by using a spirograph. Clin Neuropharmacol. 1992;15:315–21.

    Article  PubMed  CAS  Google Scholar 

  14. Komatsu S, Kirino E, Inoue Y, Arai H. Risperidone withdrawal-related respiratory dyskinesia: a case diagnosed by spirography and fiberoscopy. Clin Neuropharmacol. 2005;28:90–3.

    Article  PubMed  Google Scholar 

  15. Gregory RP, Smith PT, Rudge P. Tardive dyskinesia presenting as severe dysphagia. J Neurol Neurosurg Psychiatry. 1992;55:1203–4.

    Article  PubMed  CAS  Google Scholar 

  16. Hayashi T, Nishikawa T, Koga I, Uchida Y, Yamawaki S. Life-threatening dysphagia following prolonged neuroleptic therapy. Clin Neuropharmacol. 1997;20:77–81.

    Article  PubMed  CAS  Google Scholar 

  17. Aino I, Saigusa H, Nakamura T, Matsuoka C, Komachi T, Kokawa T. Progressive dysphagia with peculiar laryngeal movement induced by tardive dystonia. Nihon Jibiinkoka Gakkai Kaiho. 2006;109:786–8.

    Article  Google Scholar 

  18. Agarwal PA, Ichaporia NR. Lupenthixol-induced tardive dystonia presenting as severe dysphagia. Neurol India. 2010;58:784–5.

    Article  PubMed  Google Scholar 

  19. Duggal HS, Mendhekar DN. Risperidone-induced tardive pharyngeal dystonia presenting with persistent dysphagia: a case report. J Clin Psychiatry. 2008;10:161–2.

    Google Scholar 

  20. Kasantikul D. Drug-induced akathisia and suicidal tendencies in psychotic patients. J Med Assoc Thai. 1998;81:551–3.

    PubMed  CAS  Google Scholar 

  21. Ayd Jr FJ. Akathisia and suicide: fact or myth? Int Drug Ther Newsl. 1988;23:37–9.

    Google Scholar 

  22. Yassa R, Jones BD. Complications of tardive dyskinesia: a review. Psychosomatics. 1985;26:305–13.

    Article  PubMed  CAS  Google Scholar 

  23. Wright MT. Antiemetics, akathisia, and pregnancy. Psychosomatics. 2007;48:461–6.

    Article  PubMed  Google Scholar 

  24. Hashimoto T, Naiot K, Kitazawa K, Imai S, Goto T. Pallidotomy for severe tardive jaw-opening dystonia. Stereotact Funct Neurosurg. 2010;88:105–8.

    Article  PubMed  Google Scholar 

  25. Esper CD, Freeman A, Factor SA. Lingual protrusion dystonia: frequency, etiology and botulinum toxin therapy. Parkinsonism Relat Disord. 2010;16:438–41.

    Article  PubMed  Google Scholar 

  26. Schneider SA, Udani V, Sankhla CS, Bhatia KP. Recurrent acute dystonic reaction and oculogyric crisis despite withdrawal of dopamine receptor blocking drugs. Mov Disord. 2009;24:1226–9.

    Article  PubMed  Google Scholar 

  27. Szymanski S, Lieberman JA, Safferman A, Galkowski B. Rib fractures as an unusual complication of severe tardive dystonia. J Clin Psychiatry. 1993;54:160.

    PubMed  CAS  Google Scholar 

  28. Leung C, Chung DW, Kam IW, Wat KH. Multiple rib fractures secondary to severe tardive dystonia and respiratory dyskinesia. J Clin Psychiatry. 2000;61:215–6.

    Article  PubMed  CAS  Google Scholar 

  29. Lazarus AL, Toglia JU. Fatal myoglobinuric renal failure in a patient with tardive dyskinesia. Neurology. 1985;35:1055–7.

    Article  PubMed  CAS  Google Scholar 

  30. Sacks OW, Kohl M. L-dopa and oculogyric crises. Lancet. 1970;2:215–6.

    Article  PubMed  CAS  Google Scholar 

  31. Yoshida I, Sakaguchi Y, Matsuishi T, et al. Acute accidental overdosage of haloperidol in children. Acta Paediatr. 1993;82:877–80.

    PubMed  CAS  Google Scholar 

  32. Burke RE, Reches A, Traub MM, Ilson J, Swash M, Fahn S. Tetrabenazine induces acute dystonic reactions. Ann Neurol. 1985;17:200–2.

    Article  PubMed  CAS  Google Scholar 

  33. Reeves AL, So EL, Sharbrough FW, Krahn LE. Movement disorders associated with the use of gabapentin. Epilepsia. 1996;37:988–90.

    Article  PubMed  CAS  Google Scholar 

  34. Shafir Y, Levy Y, Ben-Amital D, Nitzan M, Stenherz R. Oculogyric crisis due to domperidone therapy. Helv Paediatr Acta. 1985;40:95.

    Google Scholar 

  35. Gorman M, Barkely GL. Oculogyric crisis induced by carbamazepine. Epilepsia. 1995;36:1158–60.

    Article  PubMed  CAS  Google Scholar 

  36. Veerapandiyan A, Gallentine WB, Winchester SA, Baker J, Kansagra SM, Mikati MA. Oculogyric crises secondary to lamotrigine overdosage. Epilepsia. 2011;52:e4–6.

    Article  PubMed  CAS  Google Scholar 

  37. Fraunfelder FW, Fraunfelder FT. Oculogyric crisis in patients taking cetirizine. Am J Ophthalmol. 2004;137:355–7.

    Article  PubMed  Google Scholar 

  38. Tahiroglu AY, Avci A. Polypharmacy and EPS in a child; a case report. Psychopharmacol Bull. 2007;40:129–33.

    PubMed  Google Scholar 

  39. Sandyk R. Oculogyric crisis induced by lithium carbonate. Eur Neurol. 1984;23:92–4.

    Article  PubMed  CAS  Google Scholar 

  40. Lamberti P, de Mari M, Iliceto G, Caldarola M, Serlenga L. Effect of l-dopa on oculogyric crises in a case of dopa-responsive dystonia. Mov Disord. 1993;8:236–7.

    Article  PubMed  CAS  Google Scholar 

  41. Kakigi R, Shibasaki H, Katafuchi Y, Iyatomi I, Kuroda Y. The syndrome of bilateral paramedian thalamic infarction associated with oculogyric crisis. Clin Neurol. 1986;69:951–3.

    Google Scholar 

  42. Della MG, Frisullo G, Vollono C, et al. Oculogyric crisis in a midbrain lesion. Arch Neurol. 2011;68:390–1.

    Article  Google Scholar 

  43. Heimburger RF. Positional oculogyric crises. J Neurosurg. 1988;69:951–3.

    Article  PubMed  CAS  Google Scholar 

  44. Lee MS, Kim YD, Lyoo CH. Oculogyric crisis as an initial manifestation of Wilson’s disease. Neurology. 1999;52:1714–5.

    Article  PubMed  CAS  Google Scholar 

  45. Schneider SA, Aggarwal A, Bhatt M, et al. Severe tongue protrusion dystonia: clinical syndromes and possible treatment. Neurology. 2006;67:940–3.

    Article  PubMed  CAS  Google Scholar 

  46. Horiguchi J, Inami Y. Effect of clonazepam on neuroleptic-induced oculogyric crisis. Acta Psychiatr Scand. 1989;80:521–3.

    Article  PubMed  CAS  Google Scholar 

  47. Hennigs JM, Krause E, Botzel K, Wetter TC. Successful treatment of tardive lingual dystonia with botulinum toxin: case report and review of the literature. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:1167–71.

    Article  Google Scholar 

  48. Burke RE, Kang U, Jankovic J, Miller LG, Fahn S. Tardive akathisia: an analysis of clinical features and response to open therapeutic trials. Mov Disord. 1989;4:157–75.

    Article  PubMed  CAS  Google Scholar 

  49. Kang UJ, Fahn S. Management of tardive dyskinesia. Ration Drug Ther. 1988;22:1–7.

    PubMed  CAS  Google Scholar 

  50. Kang UJ, Burke RE, Fahn S. Natural history and treatment of tardive dystonia. Mov Disord. 1986;1:193–208.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Columbia University Medical Center, New York, NY, USA

    Paul E. Greene M.D.

  2. Movement Disorders Division, Mount Sinai School of Medicine, 5 East 98th, First floor, 1138, New York, NY, 10029-6574, USA

    Steven J. Frucht M.D.

Authors
  1. Paul E. Greene M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Steven J. Frucht M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steven J. Frucht M.D. .

Editor information

Editors and Affiliations

  1. , Neurology, Columbia University Medical Center, West 168th St. Suite 310 710, New York, 10032, USA

    Steven J. Frucht

Electronic Supplementary Material

Movement_Disorders_Emergencies_C11.mov (110,877 KB)

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Greene, P.E., Frucht, S.J. (2013). Tardive and Neuroleptic-Induced Emergencies. In: Frucht, S. (eds) Movement Disorder Emergencies. Current Clinical Neurology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-835-5_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-835-5_11

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60761-834-8

  • Online ISBN: 978-1-60761-835-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation